This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Conflicted on These Healthcare Names: Moderna (MRNA) and Scienture Holdings (SCNX)

Tipranks - Tipranks - Wed Jun 17, 11:56AM CDT

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Moderna (MRNA) and Scienture Holdings (SCNX).

Claim 55% Off TipRanks

Moderna (MRNA)

William Blair analyst Myles Minter reiterated a Hold rating on Moderna today. The company’s shares closed last Tuesday at $55.44.

According to TipRanks.com, Minter is a 5-star analyst with an average return of 31.4% and a 57.7% success rate. Minter covers the Healthcare sector, focusing on stocks such as Contineum Therapeutics, Inc. Class A, CAMP4 Therapeutics Corporation, and Neumora Therapeutics, Inc. ;'>

The word on The Street in general, suggests a Hold analyst consensus rating for Moderna with a $44.76 average price target, a -14.3% downside from current levels. In a report issued on June 1, Bernstein also maintained a Hold rating on the stock.

See the top stocks recommended by analysts >>

Scienture Holdings (SCNX)

Maxim Group analyst Naz Rahman reiterated a Buy rating on Scienture Holdings yesterday and set a price target of $1.50. The company’s shares closed last Tuesday at $0.37.

According to TipRanks.com, Rahman ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -11.2% and a 34.2% success rate. Rahman covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, Galmed Pharmaceuticals, and Xtant Medical Holdings. ;'>

Scienture Holdings has an analyst consensus of Moderate Buy, with a price target consensus of $1.50.

Read More on MRNA:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).